rs757058932
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004714.3(DYRK1B):c.1778G>A(p.Arg593Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000755 in 1,457,272 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R593W) has been classified as Uncertain significance.
Frequency
Consequence
NM_004714.3 missense
Scores
Clinical Significance
Conservation
Publications
- abdominal obesity-metabolic syndrome 3Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYRK1B | NM_004714.3 | c.1778G>A | p.Arg593Gln | missense_variant | Exon 11 of 11 | ENST00000323039.10 | NP_004705.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD2 exomes AF: 0.00000436 AC: 1AN: 229108 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000755 AC: 11AN: 1457272Hom.: 0 Cov.: 33 AF XY: 0.00000690 AC XY: 5AN XY: 724746 show subpopulations
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1778G>A (p.R593Q) alteration is located in exon 11 (coding exon 10) of the DYRK1B gene. This alteration results from a G to A substitution at nucleotide position 1778, causing the arginine (R) at amino acid position 593 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DYRK1B protein function. This variant has not been reported in the literature in individuals with DYRK1B-related conditions. This variant is present in population databases (rs757058932, ExAC 0.04%). This sequence change replaces arginine with glutamine at codon 593 of the DYRK1B protein (p.Arg593Gln). The arginine residue is moderately conserved and there is a small physicochemical difference between arginine and glutamine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at